Your browser doesn't support javascript.
loading
LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).
Ma, Ting Martin; Czernin, Johannes; Felix, Carol; Alano, Rejah; Wilhalme, Holly; Valle, Luca; Steinberg, Michael L; Dahlbom, Magnus; Reiter, Robert E; Rettig, Matthew B; Cao, Minsong; Calais, Jeremie; Kishan, Amar U.
Affiliation
  • Ma TM; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
  • Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
  • Felix C; Physics and Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Alano R; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
  • Wilhalme H; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
  • Valle L; Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
  • Dahlbom M; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
  • Reiter RE; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
  • Rettig MB; Physics and Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Cao M; Department of Urology, University of California, Los Angeles, CA, USA.
  • Calais J; Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
BJU Int ; 132(1): 65-74, 2023 07.
Article in En | MEDLINE | ID: mdl-36797449
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: